









市场行情
/
股票
/
nasdaq-shc
/

Sotera Health Co

SHC

16.830USD

-0.070-0.41%

收盘 12/12, 16:00（美东）报价延迟15分钟

4.78B总市值

86.17市盈率 TTM



Sotera Health Co

16.830

-0.070-0.41%

概览公司财务分析

概览

公司

财务

分析

关于 Sotera Health Co 公司

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Sotera Health Co简介



公司代码SHC

公司名称Sotera Health Co

上市日期Nov 20, 2020

CEOPetras (Michael B)

员工数量3000

证券类型Ordinary Share

年结日Nov 20

公司地址9100 South Hills Blvd, Suite 300

城市BROADVIEW HEIGHTS

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编44147

电话14402621410

网址https://soterahealth.com/

公司代码SHC

上市日期Nov 20, 2020

CEOPetras (Michael B)

Sotera Health Co公司高管



名称

名称/职务

职务

持股

持股变动

Ms. Ann R. Klee

Independent Director

125.96K

+17.91%

Mr. Ruoxi Chen

Independent Director

80.78K

+31.03%

Mr. Vincent K. (Vince) Petrella, CPA

Lead Independent Director

80.78K

+31.03%

Ms. Karen A. Flynn

Independent Director

39.22K

+95.24%

Mr. Jonathan M. (Jon) Lyons

Chief Financial Officer, Senior Vice President

13.71K

-45.63%

Mr. Jason Peterson

Vice President and Treasurer

Dr. David E. Wheadon, M.D.

Independent Director

Mr. Constantine S. (Dean) Mihas

Independent Director

Mr. Alexander (Alex) Dimitrief

Senior Vice President, General Counsel

Mr. Sean L. Cunningham

Independent Director

名称

名称/职务

职务

持股

持股变动

Ms. Ann R. Klee

Independent Director

125.96K

+17.91%

Mr. Ruoxi Chen

Independent Director

80.78K

+31.03%

Mr. Vincent K. (Vince) Petrella, CPA

Lead Independent Director

80.78K

+31.03%

Ms. Karen A. Flynn

Independent Director

39.22K

+95.24%

Mr. Jonathan M. (Jon) Lyons

Chief Financial Officer, Senior Vice President

13.71K

-45.63%

Mr. Jason Peterson

Vice President and Treasurer

收入明细

单位: USD更新时间: 10月6日周一

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

616.68M

56.04%

Canada

208.89M

18.98%

Europe

196.01M

17.81%

Other

78.86M

7.17%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月21日周五

持股股东

股东类型

持股股东

占比

Warburg Pincus LLC

12.00%

GTCR Golder Rauner, LLC

10.28%

Darsana Capital Partners LP

8.80%

The Vanguard Group, Inc.

5.78%

BlackRock Institutional Trust Company, N.A.

4.87%

其他

58.25%

持股股东

占比

Warburg Pincus LLC

12.00%

GTCR Golder Rauner, LLC

10.28%

Darsana Capital Partners LP

8.80%

The Vanguard Group, Inc.

5.78%

BlackRock Institutional Trust Company, N.A.

4.87%

其他

58.25%

股东类型

持股股东

占比

Hedge Fund

26.25%

Private Equity

22.29%

Investment Advisor

20.46%

Investment Advisor/Hedge Fund

9.59%

Individual Investor

2.34%

Research Firm

0.75%

Pension Fund

0.42%

Sovereign Wealth Fund

0.35%

Bank and Trust

0.24%

其他

17.31%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

470

259.09M

91.20%

-33.54M

2025Q2

470

278.88M

98.25%

-13.55M

2025Q1

484

279.71M

98.54%

-14.16M

2024Q4

491

273.89M

96.62%

-15.65M

2024Q3

489

274.82M

97.04%

-16.48M

2024Q2

489

271.96M

96.07%

-20.06M

2024Q1

463

270.40M

95.52%

-12.51M

2023Q4

463

265.31M

93.87%

-20.11M

2023Q3

459

263.78M

93.33%

-20.82M

2023Q2

463

262.21M

92.81%

-22.94M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Warburg Pincus LLC

61.82M

21.77%

-12.00M

-16.26%

Sep 05, 2025

GTCR Golder Rauner, LLC

41.22M

14.51%

-8.00M

-16.26%

Sep 05, 2025

Darsana Capital Partners LP

20.01M

7.04%

Jun 30, 2025

The Vanguard Group, Inc.

14.87M

5.24%

+13.34K

+0.09%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.42M

4.37%

+31.86K

+0.26%

Jun 30, 2025

Sculptor Capital Management, Inc

14.75M

5.19%

+3.25M

+28.26%

Sep 04, 2025

Sessa Capital

6.30M

2.22%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

9.05M

3.19%

+1.01M

+12.53%

Jun 30, 2025

Sachem Head Capital Management LP

7.91M

2.78%

Jun 30, 2025

Janus Henderson Investors

6.05M

2.13%

-649.90K

-9.70%

Jun 30, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

Brandes US Small-Mid Cap Value ETF

1.33%

First Trust Health Care Alphadex Fund

0.92%

Harbor Long-Short Equity ETF

0.56%

Gotham 1000 Value ETF

0.23%

Timothy Plan US Small Cap Core ETF

0.18%

Nuveen ESG Small-Cap ETF

0.16%

BNY Mellon US Small Cap Core Equity ETF

0.12%

WisdomTree US MidCap Fund

0.12%

Strive Small-Cap ETF

0.11%

John Hancock Multifactor Small Cap ETF

0.11%

Brandes US Small-Mid Cap Value ETF

占比1.33%

First Trust Health Care Alphadex Fund

占比0.92%

Harbor Long-Short Equity ETF

占比0.56%

Gotham 1000 Value ETF

占比0.23%

Timothy Plan US Small Cap Core ETF

占比0.18%

Nuveen ESG Small-Cap ETF

占比0.16%

BNY Mellon US Small Cap Core Equity ETF

占比0.12%

WisdomTree US MidCap Fund

占比0.12%

Strive Small-Cap ETF

占比0.11%

John Hancock Multifactor Small Cap ETF

占比0.11%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Sotera Health Co的前五大股东是谁？



Sotera Health Co 的前五大股东如下：
Warburg Pincus LLC持有股份：61.82M，占总股份比例：21.77%。
GTCR Golder Rauner, LLC持有股份：41.22M，占总股份比例：14.51%。
Darsana Capital Partners LP持有股份：20.01M，占总股份比例：7.04%。
The Vanguard Group, Inc.持有股份：14.87M，占总股份比例：5.24%。
BlackRock Institutional Trust Company, N.A.持有股份：12.42M，占总股份比例：4.37%。